What is the recommended management after a hemodialysis session?

Management After Hemodialysis Session

The most critical immediate post-dialysis management involves proper blood sampling technique using the slow flow/stop pump method, followed by systematic monitoring for complications, assessment of dialysis adequacy, and optimization of patient comfort to prevent premature termination of future sessions. 1

Immediate Post-Dialysis Procedures

Blood Sampling for Adequacy Assessment

The timing and technique of post-dialysis blood urea nitrogen (BUN) sampling is crucial for accurate assessment of dialysis adequacy. Use the slow flow/stop pump sampling technique at 0.25-0.50 minutes after dialysis ends to obtain the most accurate measurement 1:

Slow Flow Technique:

• Turn off dialysate flow and reduce ultrafiltration rate to 50 mL/h or minimum setting
• Decrease blood flow to 50-100 mL/min for 15 seconds (this clears dead space and prevents access recirculation)
• Draw blood sample from arterial sampling port closest to patient while pump runs at 50-100 mL/min
• Stop blood pump and complete disconnection per unit protocol 1

Stop Pump Technique:

• Follow same initial steps, then immediately stop blood pump
• Clamp arterial and venous blood lines
• Draw blood from arterial sampling port or arterial needle tubing after disconnection 1

Critical timing consideration: Sampling at time zero falsely decreases BUN due to recirculated blood. Waiting 2-10 minutes allows urea rebound to occur, falsely increasing BUN and underestimating dialysis adequacy. The 0.25-0.50 minute window provides the index measurement before significant rebound 1.

Post-Session Clinical Assessment

Review Treatment Parameters

Immediately after each session, systematically review 1:

Blood flow and dialysate parameters:

• Compare prescribed versus actual blood flow rate (Qb)
• Verify dialysate flow rate (Qd) matched prescription
• Check prepump arterial pressures (should not exceed -200 mmHg)
• Document any pressure alarms or deviations

Treatment time verification:

• Confirm actual treatment time matched prescribed duration
• Document any interruptions, early terminations, or late starts
• Note patient arrival time and any delays 1

Clinical events during session:

• Hypotension episodes
• Muscle cramps
• Chest pain
• Any events requiring blood flow reduction or treatment modification 1

Access Site Management

For arteriovenous fistulas/grafts:

• Apply appropriate pressure to cannulation sites (avoid excessive pressure that occludes flow)
• Assess for adequate hemostasis
• Check for thrill/bruit to confirm patency
• Monitor for hematoma formation

For buttonhole cannulation (if used):

• Apply mupirocin antibacterial cream to reduce infection risk 2
• Consider rope-ladder cannulation as preferred method unless topical antimicrobial prophylaxis is consistently used 2

For tunneled catheters:

• Use closed connector devices to reduce infection risk 2
• Follow strict aseptic technique during disconnection

Monitoring for Complications

Immediate Post-Dialysis Period

Hypotension monitoring:

• Any symptomatic BP decrease or nadir systolic BP <90 mmHg requires reassessment 3
• Evaluate ultrafiltration rate, treatment time, interdialytic weight gain, and dry weight estimation
• Review antihypertensive medications
• Do not compromise euvolemia or adequate dialysis time to avoid hypotension 3

Intradialytic hypertension:

• Systolic BP increase >10 mmHg from pre- to post-dialysis in ≥4 of 6 consecutive treatments warrants extensive evaluation 3
• Obtain out-of-unit BP measurements
• Critically reassess dry weight and volume status 3

Respiratory Assessment

Monitor for dyspnea, which may indicate 4:

• Residual fluid overload despite ultrafiltration
• Cardiac dysfunction
• Impaired lung performance
• Note: Single dialysis session improves lung volume and gas exchange primarily through fluid removal 4

Adequacy Assessment and Quality Improvement

Monthly Monitoring Requirements

Measure delivered dialysis dose at least monthly using Kt/V or urea reduction ratio (URR) 1:

• Target delivered Kt/V ≥1.2 or URR ≥65%
• Prescribe doses higher than minimum targets to account for variability and prevent sessions falling below threshold 1
• Increase monitoring frequency for non-compliant patients or when adequacy targets not met

When Adequacy Falls Below Target

Primary assessment algorithm 1:

1. Review blood sampling technique:

   • Was predialysis sample diluted with saline?
   • Was predialysis sample drawn after dialysis started?
   • Was postdialysis sample drawn before dialysis ended?
   • Was postdialysis sample drawn >5 minutes after dialysis (urea rebound)?

2. Verify treatment time:

   • Patient late arrival
   • Early termination (patient request vs. clinical events)
   • Treatment interruptions
   • Needle problems requiring recannulation

3. Check clearance parameters:

   • Blood flow rate achieved
   • Dialyzer type and reuse status
   • Access recirculation (perform slow flow/stop pump test if indicated)
   • Blood pump calibration accuracy

Optimizing Patient Comfort and Adherence

Without compromising delivered dialysis dose, implement strategies to prevent intradialytic symptoms 1:

For Recurrent Hypotension and Cramps

Implement in this order 1:

1. Avoid excessive ultrafiltration:

   • Reevaluate estimated dry weight (EDW)
   • Look for signs of improving nutrition (increasing albumin, creatinine, NPCR) with hypotension—suggests EDW too low
   • Counsel on fluid intake reduction

2. Slow ultrafiltration rate:

   • Extend treatment time to reduce hourly UF rate
   • Consider isolated ultrafiltration (separate from diffusive clearance)

3. Dialysate modifications:

   • Increase dialysate sodium concentration
   • Switch from acetate to bicarbonate-buffered dialysate
   • Reduce dialysate temperature

4. Pharmacologic interventions:

   • Administer midodrine pre-dialysis
   • Correct anemia per guidelines
   • Consider supplemental oxygen 1

Patient Education and Adherence

Address common causes of premature termination 1:

• 70% of medical terminations due to cramps
• 48% due to feeling sick
• 15% due to symptomatic hypotension

Key message: Reducing blood flow and ultrafiltration in response to symptoms compromises dialysis adequacy. Prevention through prescription modification is superior to reactive management 1.

Special Considerations for Intensive Hemodialysis

For patients on long or long-frequent hemodialysis (≥5.5 hours per session) 2:

Dialysate calcium:

• Use dialysate calcium ≥1.50 mmol/L
• Maintain neutral or positive calcium balance
• Avoid predialysis hypercalcemia and PTH oversuppression

Phosphate management:

• Add phosphate to dialysate if hypophosphatemia persists after:
  • Stopping phosphate binders
  • Liberalizing diet
• Target: maintain predialysis phosphate in normal range 2

Infection Control

Environmental cleaning after each patient 5:

• Clean all surfaces with intermediate-level disinfectant
• For blood spills: two-step process with tuberculocidal disinfectant or 1:100 hypochlorite solution
• Disinfect hemodialysis machine internal pathways at end of each day (heat preferred over chemical) 5

Medication Dosing Considerations

For patients receiving outpatient parenteral antimicrobial therapy 6:

• Utilize existing vascular access for thrice-weekly post-dialytic administration
• Supported agents: vancomycin, aminoglycosides, cefazolin, ceftazidime, cefepime, ertapenem, daptomycin
• Administer after dialysis sessions to avoid removal during treatment 6

Common Pitfalls to Avoid

1. Sampling too early (time zero): Falsely lowers BUN, overestimates adequacy
2. Sampling too late (>5 minutes): Urea rebound falsely raises BUN, underestimates adequacy
3. Targeting minimum Kt/V values: Prescribe higher to account for variability
4. Compromising treatment time to avoid symptoms: Modify prescription instead
5. Using hypotension to define dry weight: Reassess volume status comprehensively
6. Inadequate documentation: Record actual vs. prescribed parameters for every session